Tg Therapeutics Inc (0VGI)
LSE
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -93.017 | -155.721 | -191.695 | -140.187 | -70.85 | -69.255 | -69.203 | 4.844 |
Return on Equity (%) | -113.871 | -230.361 | -381.158 | -551.854 | -100.143 | -92.029 | -134.128 | 11.568 |
Return on Invested Capital (%) | -145.034 | -244.633 | -412.893 | -399.157 | -93.065 | -87.387 | -101.568 | 10.833 |
Operating Margin (%) | -51482.237 | -77944.737 | -114132.895 | -110252.632 | -179639.474 | -5119.794 | -6755.619 | 10.989 |
Net Profit Margin (%) | -51482.237 | -77944.737 | -114132.895 | -113730.921 | -183803.289 | -5204.081 | -7121.544 | 5.423 |
Book Value Per Share | 0.558 | 0.835 | 0.258 | 0.327 | 3.535 | 1.582 | 0.379 | 0.995 |
Earnings Per Share | -1.244 | -1.495 | -1.928 | -1.497 | -1.904 | -2.33 | -1.3 | 0.079 |
Cash Per Share | 0.398 | 0.716 | 0.466 | 0.975 | 3.773 | 2.001 | 0.671 | 0.579 |
Working Capital Per Share | 0.54 | 0.825 | 0.446 | 0.56 | 3.573 | 1.778 | 0.755 | 1.646 |
Operating Profit Per Share | 0.002 | 0.002 | 0.002 | 0.001 | 0.001 | 0.041 | 0.017 | 1.369 |
EBIT Per Share | -1.244 | -1.495 | -1.928 | -1.497 | -1.904 | -2.33 | -1.3 | 0.081 |
EBITDA Per Share | -1.244 | -1.495 | -1.928 | -1.497 | -1.904 | -2.33 | -1.3 | 0.081 |
Free Cash Flow Per Share | -1.24 | -1.496 | -1.928 | -1.496 | -1.903 | -2.33 | -1.302 | 0.078 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 56,78M | 73,14M | 83,87M | 109,38M | 140,58M | 143,25M | 146,39M | 154,42M |
Capitalisation boursière | 0 |
Ratio cours/bénéfice | 402,07 |
Ratio prix/ventes | 21,81 |
Ratio prix/liquidités | 54,85 |
Ratio prix/valeur comptable | 31,76 |
Rendement de dividende | - |
Actions en circulation | 154,42M |
Volume moyen (1 semaine) | 0 |
Volume moyen (1 mois) | 0 |
Variation sur 52 semaines | - |
Plus haut sur 52 semaines | - |
Plus bas sur 52 semaines | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales